Literature DB >> 20032586

Fasting plasma glucose and incidence of diabetes --- implication for the threshold for impaired fasting glucose: results from the population-based Omiya MA cohort study.

Masayuki Kato1, Mitsuhiko Noda, Hiroshi Suga, Masahiko Matsumoto, Yasunori Kanazawa.   

Abstract

AIM: In 2003, the American Diabetes Association recommended that the threshold for diagnosing impaired fasting glucose (IFG) should be lowered from 6.1 mmol/L (110 mg/dL) to 5.6 mmol/L (100 mg/dL). To discuss the diagnostic threshold for IFG, the association between fasting plasma glucose (FPG) and the risk of future diabetes must be known; however, data regarding this relation in the Japanese population are scarce. The aim of this study was to determine the relation between FPG and the risk of future diabetes in the Japanese general population.
METHODS: A retrospective cohort study was conducted using data from annual health check-ups performed in Omiya city. A total of 11,369 subjects between the ages of 40-79 years who were not diabetic at baseline were followed for seven years. Diabetes was defined as FPG > or =126 mg/dL or self-report.
RESULTS: The incidence of diabetes increased as the baseline FPG level increased and a similar pattern was observed irrespective of sex or age. The hazard ratios compared with subjects with FPG <85 mg/ dL adjusted for possible confounding factors were 3.83 (95% confidence interval (95% CI); 2.41-6.08) for subjects with 100 to 104 mg/dL FPG and 7.87 [corrected] (95% CI; 4.98-12.4) for subjects with 105 to 109 mg/dL FPG.
CONCLUSIONS: Subjects with 100-109 mg/dL FPG have an appreciable risk of diabetes that cannot be considered as "normal" and should be notified of their potential risk of developing diabetes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20032586     DOI: 10.5551/jat.1792

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  5 in total

1.  Differences in the risk of fatty liver for onset of impaired fasting glucose according to baseline plasma glucose levels.

Authors:  Teruki Miyake; Masashi Hirooka; Osamu Yoshida; Shinya Furukawa; Teru Kumagi; Mitsuhito Koizumi; Shin Yamamoto; Taira Kuroda; Eiji Arimitsu; Eiji Takeshita; Masanori Abe; Kohichiro Kitai; Bunzo Matsuura; Yoichi Hiasa
Journal:  J Gastroenterol       Date:  2016-06-24       Impact factor: 7.527

2.  Haemoglobin A1c cut-off point to identify a high risk group of future diabetes: results from the Omiya MA Cohort Study.

Authors:  M Kato; M Noda; H Suga; T Nakamura; M Matsumoto; Y Kanazawa
Journal:  Diabet Med       Date:  2012-07       Impact factor: 4.359

Review 3.  Incidence of type 2 diabetes in Japan: a systematic review and meta-analysis.

Authors:  Atsushi Goto; Maki Goto; Mitsuhiko Noda; Shoichiro Tsugane
Journal:  PLoS One       Date:  2013-09-06       Impact factor: 3.240

4.  Hyperuricemia is a risk factor for the onset of impaired fasting glucose in men with a high plasma glucose level: a community-based study.

Authors:  Teruki Miyake; Teru Kumagi; Shinya Furukawa; Masashi Hirooka; Keitarou Kawasaki; Mitsuhito Koizumi; Yasuhiko Todo; Shin Yamamoto; Masanori Abe; Kohichiro Kitai; Bunzo Matsuura; Yoichi Hiasa
Journal:  PLoS One       Date:  2014-09-19       Impact factor: 3.240

5.  Fasting plasma glucose level in the range of 90-99 mg/dL and the risk of the onset of type 2 diabetes: Population-based Panasonic cohort study 2.

Authors:  Chihiro Munekawa; Hiroshi Okada; Masahide Hamaguchi; Momoko Habu; Kazushiro Kurogi; Hiroaki Murata; Masato Ito; Michiaki Fukui
Journal:  J Diabetes Investig       Date:  2021-10-23       Impact factor: 4.232

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.